Lee Albert Birnbaum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lee Albert Birnbaum has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Justin R. Mascitelli
Department of Neurosurgery, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
9 shared publications - Fadi Al Saiegh
Department of Neurosurgery, University of Texas Health Science Center, San Antonio, TX, USA
4 shared publications - Anqi Luo
Department of Neurology, The University of Texas at San Antonio Health Science Center, San Antonio, United States
3 shared publications M Webb
Neurosurgery, UT Health Science Center San Antonio, San Antonio, TX, USA
3 shared publications- Matthew Webb
Department of Neurosurgery, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA
3 shared publications - Michael Gaub
Department of Neurosurgery, The University of Texas Health Science Center San Antonio, San Antonio, Texas, USA
3 shared publications
Latest Publications
- Open Access
- 22 May 2025
- Published by SAGE Publications in Interventional Neuroradiology
Macrowire-only direct aspiration first-pass technique for endovascular mechanical thrombectomy: Multicenter technical series using the 0.035″ aristotle Colossus wire
Background: Larger “macrowires” may facilitate microcatheter-free delivery of large-bore aspiration catheters (ACs) for intracranial endovascular mechanical thrombectomy. We examined the safety and efficacy of the Aristotle Colossus Guidewire for this use. Methods: In this retrospective analysis of prospective data from 12 institutions, we identified anterior circulation endovascular mechanical thrombectomy cases involving the Aristotle Colossus guidewire over a 12-month period. The primary efficacy endpoint was successful delivery of the AC to the site without the use of adjunct devices. Multivariable logistic regression was performed with clinically relevant covariables. Results: In 122 patients (median age 74 years (interquartile range (IQR) 63–82)), most intracranial occlusions were in the M1 segment of the middle cerebral artery (95/122, 78.0%). The primary endpoint of microcatheter-free AC delivery was met in 87.7% (107/122) of patients; 93/122 (76.2%) patients underwent microcatheter-free delivery with successful reperfusion via contact aspiration (modified thrombolysis in cerebral infarction grade ≥ 2B). The median number of passes was 1 (IQR 1–2). Multivariable regression demonstrated that severe internal carotid artery tortuosity or cervical loop presence (odds ratio (OR): 0.09, 95% confidence interval (CI): 0.01–0.54, p = 0.01) and presence of intracranial atherosclerotic disease (OR: 0.15, 95% CI: 0.03–0.83, p = 0.03) were significantly associated with lower odds of successful AC delivery over the guidewire. Intraprocedural vasospasm occurred in 4.9% (6/122) of cases; there were no reports of vessel dissection or perforation. Conclusions: We demonstrate the favorable performance of the Aristotle Colossus guidewire for anterior circulation ischemic stroke intervention. The macrowire appears to safely facilitate navigation of the neurovasculature by large-bore ACs without the need for microcatheter and/or stentriever.
- 22 May 2025
- Published by SAGE Publications in Interventional Neuroradiology
Open AccessMacrowire-only direct aspiration first-pass technique for endovascular mechanical thrombectomy: Multicenter technical series using the 0.035″ aristotle Colossus wire
Background: Larger “macrowires” may facilitate microcatheter-free delivery of large-bore aspiration catheters (ACs) for intracranial endovascular mechanical thrombectomy. We examined the safety and efficacy of the Aristotle Colossus Guidewire for this use. Methods: In this retrospective analysis of prospective data from 12 institutions, we identified anterior circulation endovascular mechanical thrombectomy cases involving the Aristotle Colossus guidewire over a 12-month period. The primary efficacy endpoint was successful delivery of the AC to the site without the use of adjunct devices. Multivariable logistic regression was performed with clinically relevant covariables. Results: In 122 patients (median age 74 years (interquartile range (IQR) 63–82)), most intracranial occlusions were in the M1 segment of the middle cerebral artery (95/122, 78.0%). The primary endpoint of microcatheter-free AC delivery was met in 87.7% (107/122) of patients; 93/122 (76.2%) patients underwent microcatheter-free delivery with successful reperfusion via contact aspiration (modified thrombolysis in cerebral infarction grade ≥ 2B). The median number of passes was 1 (IQR 1–2). Multivariable regression demonstrated that severe internal carotid artery tortuosity or cervical loop presence (odds ratio (OR): 0.09, 95% confidence interval (CI): 0.01–0.54, p = 0.01) and presence of intracranial atherosclerotic disease (OR: 0.15, 95% CI: 0.03–0.83, p = 0.03) were significantly associated with lower odds of successful AC delivery over the guidewire. Intraprocedural vasospasm occurred in 4.9% (6/122) of cases; there were no reports of vessel dissection or perforation. Conclusions: We demonstrate the favorable performance of the Aristotle Colossus guidewire for anterior circulation ischemic stroke intervention. The macrowire appears to safely facilitate navigation of the neurovasculature by large-bore ACs without the need for microcatheter and/or stentriever.
- Open Access
- 28 February 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 71
Y-stent-assisted coiling for large wide-neck dysplastic middle cerebral artery bifurcation aneurysm: An update to procedural technique
Background: The endovascular treatment of complex middle cerebral artery (MCA) aneurysms, particularly dysplastic large MCA bifurcation aneurysms, can pose significant technical challenges. We aim to present three cases illustrating the technical nuances and challenges often encountered in Y-stent-assisted coiling (Y-SAC) for such aneurysms and provide an update on technical nuances. Methods: We present three consecutive cases of dysplastic MCA aneurysms, each >10 mm with a wide neck. We successfully performed Y-SAC in all cases on the first attempt using the “around the world” technique and used Neuroform Atlas Stent (Stryker Neurovascular, California, USA) as a distal anchor to reduce the microcatheter loop. Immediate final digital subtraction angiography showed adequate occlusion of all aneurysms. Results: All patients tolerated the procedure well and were discharged home on postoperative day (POD) 1 in all cases. The first patient required a second coiling at the aneurysm neck 6 months after initial treatment, with complete protection of the dome. The second patient’s 6-month follow-up angiogram showed complete occlusion of the aneurysm with patency of all MCA branches. Unfortunately, the third patient failed to comply with dual antiplatelet therapy after discharge and developed stent thrombosis 3 months postprocedure and passed away. Conclusion: Y-SAC is a reasonable option for large, wide-neck, MCA bifurcation aneurysms in patients who are not fit for microsurgical clipping and/or bypass surgery. Complex endovascular techniques, including aneurysm encircling and the “Atlas Stent Anchor” technique, may be necessary to complete the procedure successfully.
- 28 February 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 71
Open AccessY-stent-assisted coiling for large wide-neck dysplastic middle cerebral artery bifurcation aneurysm: An update to procedural technique
Background: The endovascular treatment of complex middle cerebral artery (MCA) aneurysms, particularly dysplastic large MCA bifurcation aneurysms, can pose significant technical challenges. We aim to present three cases illustrating the technical nuances and challenges often encountered in Y-stent-assisted coiling (Y-SAC) for such aneurysms and provide an update on technical nuances. Methods: We present three consecutive cases of dysplastic MCA aneurysms, each >10 mm with a wide neck. We successfully performed Y-SAC in all cases on the first attempt using the “around the world” technique and used Neuroform Atlas Stent (Stryker Neurovascular, California, USA) as a distal anchor to reduce the microcatheter loop. Immediate final digital subtraction angiography showed adequate occlusion of all aneurysms. Results: All patients tolerated the procedure well and were discharged home on postoperative day (POD) 1 in all cases. The first patient required a second coiling at the aneurysm neck 6 months after initial treatment, with complete protection of the dome. The second patient’s 6-month follow-up angiogram showed complete occlusion of the aneurysm with patency of all MCA branches. Unfortunately, the third patient failed to comply with dual antiplatelet therapy after discharge and developed stent thrombosis 3 months postprocedure and passed away. Conclusion: Y-SAC is a reasonable option for large, wide-neck, MCA bifurcation aneurysms in patients who are not fit for microsurgical clipping and/or bypass surgery. Complex endovascular techniques, including aneurysm encircling and the “Atlas Stent Anchor” technique, may be necessary to complete the procedure successfully.
- Open Access
- 16 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4167
Flow Diversion for Endovascular Treatment of Intracranial Aneurysms: Past, Present, and Future Directions
Flow diversion for intracranial aneurysms emerged as an efficacious and durable treatment option over the last two decades. In a paradigm shift from intrasaccular aneurysm embolization to parent vessel remodeling as the mechanism of action, the proliferation of flow-diverting devices has enabled the treatment of many aneurysms previously considered untreatable. In this review, we review the history and development of flow diverters, highlight the pivotal clinical trials leading to their regulatory approval, review current devices including endoluminal and intrasaccular flow diverters, and discuss current and expanding indications for their use. Areas of clinical equipoise, including ruptured aneurysms and wide-neck bifurcation aneurysms, are summarized with a focus on flow diverters for these pathologies. Finally, we discuss future directions in flow diversion technology including bioresorbable flow diverters, transcriptomics and radiogenomics, and machine learning and artificial intelligence.
- 16 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4167
Open AccessFlow Diversion for Endovascular Treatment of Intracranial Aneurysms: Past, Present, and Future Directions
Flow diversion for intracranial aneurysms emerged as an efficacious and durable treatment option over the last two decades. In a paradigm shift from intrasaccular aneurysm embolization to parent vessel remodeling as the mechanism of action, the proliferation of flow-diverting devices has enabled the treatment of many aneurysms previously considered untreatable. In this review, we review the history and development of flow diverters, highlight the pivotal clinical trials leading to their regulatory approval, review current devices including endoluminal and intrasaccular flow diverters, and discuss current and expanding indications for their use. Areas of clinical equipoise, including ruptured aneurysms and wide-neck bifurcation aneurysms, are summarized with a focus on flow diverters for these pathologies. Finally, we discuss future directions in flow diversion technology including bioresorbable flow diverters, transcriptomics and radiogenomics, and machine learning and artificial intelligence.
- 23 May 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (8) , 107774
Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry
- 23 May 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (8) , 107774
Door to needle time trends after transition to tenecteplase: A Multicenter Texas stroke registry
- 9 January 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 236, 108116
Development of the Circle of Willis Score (COWS) to help guide decision making during acute tandem occlusion treatment: Preliminary analysis
- 9 January 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 236, 108116
Development of the Circle of Willis Score (COWS) to help guide decision making during acute tandem occlusion treatment: Preliminary analysis
- Open Access
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A207.2-A208
E-216 Possible association of pre-surgical middle meningeal artery embolization and subdural empyema
Background Chronic subdural hematomas (cSDH) are traditionally managed by close observation with repeat neuroimaging or surgical evacuation. In recent years, middle meningeal artery embolization (MMAE) has emerged as minimally invasive treatment for cSDH. There are ongoing trials evaluating the safety and effectiveness of MMAE. Some of the ongoing debates include the timing of MMAE in relationship surgery as well as which embolic material is most effective. The relationship of MMAE to surgical infections has not been extensively studied. Methods This is a retrospective review of patients who underwent MMAE for treatment of cSDH during the time period of May 2019 to November 2022. Data collection includes patient side(s) of treatment, embolization material, pre-embolization and post-embolization neurological exams, surgical interventions, and, if any, subsequent infections. Relationship between MMAE timing/embolic material with infections was evaluated. Results A total of 80 patients were included in the analysis who had 101 MMAEs for treatment of cSDH. Thirty-seven (46.25%) patients had stand-alone MMAE, 34 (42.5%) post-surgical MMAE, 5 (6.25%) pre-surgical MMAE, and 4 (5%) pre/post-surgical MMAE. Surgeries included SEPS, burr holes, and mini craniotomies. Embolic material included polyvinyl alcohol particles (PVA) (67, 66.3%), Onyx18 (27, 26.7%), a combination of PVA with Onyx18 (6, 5.94%), and N-butyl-2-cyanoacrylate (NBCA) glue (1, 0.99%). There were a total of 5 (6.25%) infections, 3 of which were ipsilateral subdural empyema (SDE) and included and 2 of which were excluded (scalp infection and contralateral infection). The infection rate of patients with MMAE only, post-surgical MMAE, pre-surgical MMAE, and pre/post-surgical MMAE were 0/37, 0/34, 2/5, and 1/4, respectively. All 3 infections (100%) occurred in patients who had a craniotomy following MMAE. Two infections (67%) occurred with Onyx18 use and one infection (33%) occurred with PVA. No infections occurred with SEPS or burr holes. Conclusion Within the limitations of a small single center retrospective study, there may be an association with pre-surgical MMAE with Onyx18 and SDE potentially caused by extensive permanent devascularization of the dura. This finding should be examined in a larger multicenter cohort. Disclosures M. Farrell: None. K. Russell: None. M. Webb: None. F. Al-Saiegh: None. P. Rodriguez: None. L. Birnbaum: None. R. Morton: None. J. Mascitelli: None.
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A207.2-A208
Open AccessE-216 Possible association of pre-surgical middle meningeal artery embolization and subdural empyema
Background Chronic subdural hematomas (cSDH) are traditionally managed by close observation with repeat neuroimaging or surgical evacuation. In recent years, middle meningeal artery embolization (MMAE) has emerged as minimally invasive treatment for cSDH. There are ongoing trials evaluating the safety and effectiveness of MMAE. Some of the ongoing debates include the timing of MMAE in relationship surgery as well as which embolic material is most effective. The relationship of MMAE to surgical infections has not been extensively studied. Methods This is a retrospective review of patients who underwent MMAE for treatment of cSDH during the time period of May 2019 to November 2022. Data collection includes patient side(s) of treatment, embolization material, pre-embolization and post-embolization neurological exams, surgical interventions, and, if any, subsequent infections. Relationship between MMAE timing/embolic material with infections was evaluated. Results A total of 80 patients were included in the analysis who had 101 MMAEs for treatment of cSDH. Thirty-seven (46.25%) patients had stand-alone MMAE, 34 (42.5%) post-surgical MMAE, 5 (6.25%) pre-surgical MMAE, and 4 (5%) pre/post-surgical MMAE. Surgeries included SEPS, burr holes, and mini craniotomies. Embolic material included polyvinyl alcohol particles (PVA) (67, 66.3%), Onyx18 (27, 26.7%), a combination of PVA with Onyx18 (6, 5.94%), and N-butyl-2-cyanoacrylate (NBCA) glue (1, 0.99%). There were a total of 5 (6.25%) infections, 3 of which were ipsilateral subdural empyema (SDE) and included and 2 of which were excluded (scalp infection and contralateral infection). The infection rate of patients with MMAE only, post-surgical MMAE, pre-surgical MMAE, and pre/post-surgical MMAE were 0/37, 0/34, 2/5, and 1/4, respectively. All 3 infections (100%) occurred in patients who had a craniotomy following MMAE. Two infections (67%) occurred with Onyx18 use and one infection (33%) occurred with PVA. No infections occurred with SEPS or burr holes. Conclusion Within the limitations of a small single center retrospective study, there may be an association with pre-surgical MMAE with Onyx18 and SDE potentially caused by extensive permanent devascularization of the dura. This finding should be examined in a larger multicenter cohort. Disclosures M. Farrell: None. K. Russell: None. M. Webb: None. F. Al-Saiegh: None. P. Rodriguez: None. L. Birnbaum: None. R. Morton: None. J. Mascitelli: None.
- Open Access
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A161.1-A161
E-141 Development of the circle of willis score (COWS) to help guide decision making during acute tandem occlusion treatment
Introduction/Purpose Acute tandem occlusions (TOs) are challenging to treat, and controversies exist regarding both the sequence of steps as well as how to handle the proximal occlusion in the acute setting. Although there is mounting evidence that acute carotid stenting is well tolerated, there are certain situations when the practitioner may be wary of acute stenting (e.g., bleeding concerns). The purpose of this study was to develop a Circle of Willis Score (COWS) to aid in this decision making. Methods This is a retrospective review of TO patients from 2018 to 2022 treated in South Texas who had a persistent proximal occlusion following intervention (either expected or unexpected). Pre intervention CTA and intraoperative DSA were reviewed, and each patient was assigned a score 2 (complete COW), 1a (patent A1-Acomm-A1), 1p (patient Pcomm), or 0 (incompetent COW). Findings from the DSA took precedence over the CTA. Two cohorts were then created, COWS 2 versus COWS 1a/1p/0 combined. Angiographic outcomes were assessed using the mTICI score (successful reperfusion mTICI 2b-3) and clinical outcomes were assessed using discharge mRS (good outcome mRS 0-3) Results Of 68 total TO cases, 12 had a persistent proximal occlusion. There were 5/12 (41.6%) patients in the COWS 2 cohort, 7/12 (58.4%) in the COWS 1a/1p/0 cohort (5/12 COWS 1a/1p and 2/12 COWS 0). In the COWS 2 cohort there were 2 ICA-ICA occlusions and 3 ICA-MCA occlusions. In the COWS 1a/1p/0 cohort there was one ICA-ICA occlusion and 6 ICA-MCA occlusions. LKW to puncture was shorter in the COWS 2 cohort (208 min vs. 464 min) but this was skewed by 2 patients in the COWS 1a/1p/0 cohort who had very long LKW-puncture times and both still had a good clinical outcome. Successful reperfusion was higher in the COWS 2 cohort (100% vs. 71%). Good clinical outcome was significantly higher in the COWS 2 cohort (80% vs 29%). When excluding the 2 patients in the COWS 1a/1p/0 cohort who had unsuccessful reperfusion (both of whom who happened to be COWS 0), good clinical outcome was still higher in the COWS 2 cohort (80% vs 40%). Conclusion The COWS is a simple score that can be quickly applied using pre-intervention CTA and intraoperative DSA and may help practitioners predict a successful clinical outcome without proximal revascularization if there are concerns about performing an acute carotid stent during TO treatment. A completely patent COW may prevent a poor outcome with a persistent extracranial ICA occlusion. Future studies with larger sample sizes of patients are warranted to further understand the significance of intact collateral circulation in the circle of Willis when treating TOs. Disclosures S. Pathuri: None. W. Johnson: None. M. Webb: None. T. Fielder: None. F. Al-Saiegh: None. P. Rodriguez: None. L. Birnbaum: None. J. Mascitelli: None.
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A161.1-A161
Open AccessE-141 Development of the circle of willis score (COWS) to help guide decision making during acute tandem occlusion treatment
Introduction/Purpose Acute tandem occlusions (TOs) are challenging to treat, and controversies exist regarding both the sequence of steps as well as how to handle the proximal occlusion in the acute setting. Although there is mounting evidence that acute carotid stenting is well tolerated, there are certain situations when the practitioner may be wary of acute stenting (e.g., bleeding concerns). The purpose of this study was to develop a Circle of Willis Score (COWS) to aid in this decision making. Methods This is a retrospective review of TO patients from 2018 to 2022 treated in South Texas who had a persistent proximal occlusion following intervention (either expected or unexpected). Pre intervention CTA and intraoperative DSA were reviewed, and each patient was assigned a score 2 (complete COW), 1a (patent A1-Acomm-A1), 1p (patient Pcomm), or 0 (incompetent COW). Findings from the DSA took precedence over the CTA. Two cohorts were then created, COWS 2 versus COWS 1a/1p/0 combined. Angiographic outcomes were assessed using the mTICI score (successful reperfusion mTICI 2b-3) and clinical outcomes were assessed using discharge mRS (good outcome mRS 0-3) Results Of 68 total TO cases, 12 had a persistent proximal occlusion. There were 5/12 (41.6%) patients in the COWS 2 cohort, 7/12 (58.4%) in the COWS 1a/1p/0 cohort (5/12 COWS 1a/1p and 2/12 COWS 0). In the COWS 2 cohort there were 2 ICA-ICA occlusions and 3 ICA-MCA occlusions. In the COWS 1a/1p/0 cohort there was one ICA-ICA occlusion and 6 ICA-MCA occlusions. LKW to puncture was shorter in the COWS 2 cohort (208 min vs. 464 min) but this was skewed by 2 patients in the COWS 1a/1p/0 cohort who had very long LKW-puncture times and both still had a good clinical outcome. Successful reperfusion was higher in the COWS 2 cohort (100% vs. 71%). Good clinical outcome was significantly higher in the COWS 2 cohort (80% vs 29%). When excluding the 2 patients in the COWS 1a/1p/0 cohort who had unsuccessful reperfusion (both of whom who happened to be COWS 0), good clinical outcome was still higher in the COWS 2 cohort (80% vs 40%). Conclusion The COWS is a simple score that can be quickly applied using pre-intervention CTA and intraoperative DSA and may help practitioners predict a successful clinical outcome without proximal revascularization if there are concerns about performing an acute carotid stent during TO treatment. A completely patent COW may prevent a poor outcome with a persistent extracranial ICA occlusion. Future studies with larger sample sizes of patients are warranted to further understand the significance of intact collateral circulation in the circle of Willis when treating TOs. Disclosures S. Pathuri: None. W. Johnson: None. M. Webb: None. T. Fielder: None. F. Al-Saiegh: None. P. Rodriguez: None. L. Birnbaum: None. J. Mascitelli: None.
- Open Access
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A190-A191
E-189 Outcomes of tenecteplase versus alteplase after mechanical thrombectomy in a multiethnic stroke consortium registry
Introduction Intravenous (IV) tenecteplase (TNK) has emerged as an alternative to IV alteplase (tPA) in the treatment of acute ischemic stroke. Prior studies have shown non-inferiority with better reperfusion and functional outcomes after mechanical thrombectomy (MT) with TNK versus tPA. Methods Prospective thrombolytic data from a multi-center US stroke consortium was collected over a 30-month period between 2019 and 2022. National Institutes of Health stroke scale (NIHSS) at presentation, site of vessel occlusion, post-MT Thrombolysis in Cerebral Infarction (TICI) score, discharge modified Rankin Scale (mRS), discharge ambulatory status, and post-MT intracranial hemorrhage (ICH) were analyzed using non-parametric tests. ICH included parenchymal hematoma Type 2, intraventricular hemorrhage, subarachnoid hemorrhage, remote site of intraparenchymal hemorrhage outside the area of infarction, and other positive findings. Results A total of 168 patients were included for analysis, of which a third were Hispanic. With exception of ethnicity, there were no differences in patient demographics or stroke location/severity between groups (table 1). Clinical and radiographic outcome variables were comparable between groups (table 2). Conclusion In this prospective, multi-center stroke consortium study, IV TNK in comparison to tPA prior to MT for ischemic stroke resulted in non-inferior outcomes related to angiographic reperfusion and functional status at discharge. These findings compliment the current literature and include a large Hispanic US cohort. Further analysis will include expansion of contributing centers and use of propensity scoring. Disclosures M. Gaub: None. D. Ramaswamy: None. A. Cardentey: None. S. Bandela: None. G. Gealogo: None. J. Mascitelli: None. F. Al Saiegh: None. L. Birnbaum: 2; C; Rapid AI, Imperative Care.
- 30 July 2023
- Published by BMJ
- Vol. 15 (Suppl 1) , A190-A191
Open AccessE-189 Outcomes of tenecteplase versus alteplase after mechanical thrombectomy in a multiethnic stroke consortium registry
Introduction Intravenous (IV) tenecteplase (TNK) has emerged as an alternative to IV alteplase (tPA) in the treatment of acute ischemic stroke. Prior studies have shown non-inferiority with better reperfusion and functional outcomes after mechanical thrombectomy (MT) with TNK versus tPA. Methods Prospective thrombolytic data from a multi-center US stroke consortium was collected over a 30-month period between 2019 and 2022. National Institutes of Health stroke scale (NIHSS) at presentation, site of vessel occlusion, post-MT Thrombolysis in Cerebral Infarction (TICI) score, discharge modified Rankin Scale (mRS), discharge ambulatory status, and post-MT intracranial hemorrhage (ICH) were analyzed using non-parametric tests. ICH included parenchymal hematoma Type 2, intraventricular hemorrhage, subarachnoid hemorrhage, remote site of intraparenchymal hemorrhage outside the area of infarction, and other positive findings. Results A total of 168 patients were included for analysis, of which a third were Hispanic. With exception of ethnicity, there were no differences in patient demographics or stroke location/severity between groups (table 1). Clinical and radiographic outcome variables were comparable between groups (table 2). Conclusion In this prospective, multi-center stroke consortium study, IV TNK in comparison to tPA prior to MT for ischemic stroke resulted in non-inferior outcomes related to angiographic reperfusion and functional status at discharge. These findings compliment the current literature and include a large Hispanic US cohort. Further analysis will include expansion of contributing centers and use of propensity scoring. Disclosures M. Gaub: None. D. Ramaswamy: None. A. Cardentey: None. S. Bandela: None. G. Gealogo: None. J. Mascitelli: None. F. Al Saiegh: None. L. Birnbaum: 2; C; Rapid AI, Imperative Care.